InSightec Ltd. announced today that Japan's Ministry of Health, Labor and
Welfare (MHLW) has approved the company's ExAblate(R) MR-guided Focused
Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids.

"We are very pleased that the Japanese Ministry of Health has approved
the ExAblate system and that women in Japan will now have access to a
noninvasive treatment option for uterine fibroids," said Dr. Kobi Vortman,
President and Chief Executive Officer of InSightec. "The approval was based
on a growing body of evidence showing that ExAblate is a safe, effective, and
durable treatment for this widespread, life-impacting condition. ExAblate is
an outpatient procedure and patients normally return home the same day and to
work within one to two days compared to lengthy hospitalizations and recovery
times associated with more invasive procedures such as hysterectomy,
myomectomy or UAE."

ExAblate is currently the only noninvasive treatment for uterine fibroids
approved for use in Japan. Approximately 25% Japanese women will develop
symptomatic uterine fibroids, primarily during childbearing years. These
benign tumors can significantly impair functionality and degrade quality of
life resulting in significant work absences.

Using the ExAblate system, the physician uses the Magnetic Resonance
Imaging (MRI) to visualize the patient's anatomy and then aims focused
ultrasound waves at the targeted tissue to thermally ablate, or destroy it.
The MRI allows the physician to monitor and continuously adjust the treatment
in real time. The patient is consciously sedated to alleviate pain and
minimize motion.

A growing body of evidence supports the system's safety and efficacy,
including the results of a study published in the August 2007 edition of
Obstetrics and Gynecology. The study showed that ExAblate offered women
sustained relief from uterine fibroid symptoms for up to two years, with a
low incidence of side effects. The 359-patient Mayo Clinic-led collaborative
study also showed that destroying as much of the fibroid as possible leads to
the most durable symptom relief with 85% of the participants experiencing
symptom improvement after one year. Studies conducted in Japan indicate
similar results.

The ExAblate system received the CE Mark for uterine fibroids in October
2002 and US Food and Drug Administration (FDA) approval in 2004. Over 5,500
women around the world have chosen to undergo the non-invasive ExAblate
treatment for their symptomatic uterine fibroids over invasive surgery.

GE Healthcare is the approval holder and distributor of ExAblate in Japan.

About InSightec

InSightec Ltd. is a privately held company owned by Elbit Imaging,
General Electric, MediTech Advisors, LLC and employees. It was founded in
1999 to develop the breakthrough MR guided Focused Ultrasound technology and
transform it into the next generation operating room. Headquartered near
Haifa, Israel, the company has over 160 employees and has invested more than
$130 million in research, development, and clinical investigations. Its U.S.
headquarters are located in Dallas, Texas. For more information, please go
to: http://www.insightec.com/

About GE Healthcare Japan]

GE Healthcare Japan Corporation provides cutting edge medical
technologies and healthcare services that design the next-generation patient
care model by utilizing its expertise across a wide range of areas such as;
medical diagnostic imaging systems and healthcare IT equipments such as CT
(Computerized Tomography) systems and MR (Magnetic Resonance) imaging
systems, medical diagnostic drugs, biological information monitors, drug
discovery, biotechnology-based drugs, and providing support for the
management of healthcare institutes. GE Healthcare Japan Corporation was
established as the core site in Japan for the healthcare business section
within the General Electric Company (GE, based in the U.S.).

(Date:12/8/2016)... 8, 2016 Boehringer Ingelheim announced today that it ... (CEI). This is the ninth time that the company ... a Best Place to Work for LGBT Equality. Administered ... a national benchmarking report on corporate policies and practices ... transgender (LGBT) employees. "We are committed ...

(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...

(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital health ... led by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and ... to serve more consumers who are managing chronic conditions or simply want ...

(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...

(Date:12/8/2016)... ... 08, 2016 , ... Bill Mull Agencies, a Wichita-based firm ... around central Kansas, is joining the Youth Horizons organization for a charity event ... in Wichita, Youth Horizons works to empower area children from unstable, troubled, or ...

(Date:12/7/2016)... ... , ... Kenall Manufacturing, a leader in sealed healthcare lighting for more than ... multi-function, sealed, LED luminaire that meets the needs of everyone in the patient room ... , A 2’ x 4’ model features four modes: reading, ambient, standard and ...